Zobrazeno 1 - 10
of 69
pro vyhledávání: '"P. L. A. Van Daele"'
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background Autoinflammatory diseases are rare disorders of the innate immune system characterized by fever and other signs of inflammation. A feared complication of autoinflammatory diseases is the development of AA amyloidosis. AA amyloidos
Externí odkaz:
https://doaj.org/article/580038b4b5fb46d6841240b46319a593
Autor:
Laixi Xue, K. van Bilsen, M. W. J. Schreurs, M. E. J. van Velthoven, T. O. Missotten, A. A. H. J. Thiadens, R. W. A. M. Kuijpers, P. van Biezen, V. A. S. H. Dalm, J. A. M. van Laar, M. A. W. Hermans, W. A. Dik, P. L. A. van Daele, P. M. van Hagen
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: Since the late ‘90s, infliximab (Remicade®) is being used successfully to treat patients with several non-infectious immune mediated inflammatory diseases (IMIDs). In recent years, infliximab biosimilars, including Remsima® were intro
Externí odkaz:
https://doaj.org/article/e152d3e8b46f4c7a951758b552d87606
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 14, p 3395 (2019)
Mast cells are pluripotent leukocytes that reside in the mucosa and connective tissue. Recent studies show an increased prevalence of cardiovascular disease among patients with mastocytosis, which is a hematological disease that is characterized by t
Externí odkaz:
https://doaj.org/article/a1ebee9b66954674a7956a9a1c968f1a
Bioinformatic meta-analysis reveals novel differentially expressed genes and pathways in sarcoidosis
Autor:
Rogier T. A. van Wijck, Hari S. Sharma, Sigrid M. A. Swagemakers, Willem A. Dik, Hanna IJspeert, Virgil A. S. H. Dalm, Paul L. A. van Daele, P. Martin van Hagen, Peter J. van der Spek
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionSarcoidosis is a multi-system inflammatory disease of unknown origin with heterogeneous clinical manifestations varying from a single organ non-caseating granuloma site to chronic systemic inflammation and fibrosis. Gene expression studie
Externí odkaz:
https://doaj.org/article/f8a6d8e6b3d74c478ef8b365b23c0637
Autor:
A.H. Maitland-van der Zee, Marlies S. Wijsenbeek, Judith Oppenheimer, P L A van Daele, I. G. van der Sar, Catharina C. Moor, M.L. Luijendijk, Paul Brinkman
Publikováno v:
Chest, 161(3), 738-747. American College of Chest Physicians
BACKGROUND: Diagnosing sarcoidosis can be challenging, and a noninvasive diagnosticmethod is lacking. The electronic nose (eNose) technology profiles volatile organic compounds in exhaled breath and has potential as a point-of-care diagnostic tool.RE
Autor:
P. L. A. van Daele, M. C. Zillikens
Publikováno v:
Orthopaedics and Traumatology ISBN: 9789036826372
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e63537d5f88f1f04e9f8af7861a40ce
https://doi.org/10.1007/978-90-368-2638-9_22
https://doi.org/10.1007/978-90-368-2638-9_22
Autor:
P L A, van Daele
Publikováno v:
The Netherlands journal of medicine. 78(4)
Autor:
P L A, van Daele
Publikováno v:
The Netherlands journal of medicine. 78(3)
Autor:
Laixi Xue, K. van Bilsen, M. W. J. Schreurs, M. E. J. van Velthoven, T. O. Missotten, A. A. H. J. Thiadens, R. W. A. M. Kuijpers, P. van Biezen, V. A. S. H. Dalm, J. A. M. van Laar, M. A. W. Hermans, W. A. Dik, P. L. A. van Daele, P. M. van Hagen
Publikováno v:
Frontiers in Medicine, 7:418. Frontiers Media S.A.
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Background: Since the late ‘90s, infliximab (Remicade®) is being used successfully to treat patients with several non-infectious immune mediated inflammatory diseases (IMIDs). In recent years, infliximab biosimilars, including Remsima® were intro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba65c21bf17d25fa1100bf43e3827798
https://pure.eur.nl/en/publications/007aabaf-4fdc-4242-9563-c99a7f4f8ee5
https://pure.eur.nl/en/publications/007aabaf-4fdc-4242-9563-c99a7f4f8ee5
Autor:
P L A van Daele
Publikováno v:
Bijblijven. 34:160-166
Er is geen groep geneesmiddelen die zo snel groeit als de groep biologicals. Net als alle andere medicamenten hebben biologicals hun bijwerkingen. In deze bijdrage wordt op deze bijwerkingen ingegaan.